Ron Cooper

President and Chief Executive Officer

Ron Cooper, Albireo’s first President and CEO, is a global P&L leader with a track record of growing businesses, brands and organizations in the U.S. and Europe. For over 25 years, Ron worked in five different countries and held positions of increasing responsibility in sales, marketing and general management with Bristol-Myers Squibb, culminating in his role as President of Europe where he was responsible for over 30 countries with sales exceeding $4.5 billion.

While at BMS, Ron played a leadership role in several product successes, including Abilify®, Avapro®, Atripla®, Eliquis®, Orencia®, Pravachol®, Plavix®, Reyataz® Sustiva® Sprycel® and Yervoy®. Ron has successfully completed more than a dozen business development deals, including the creation of the first single tablet HIV/AIDS regimen partnership. He is a graduate of St. Francis Xavier University in Canada.

Team members

Ron Cooper

President and Chief Executive Officer

Martha (Muffy) Carter

Chief Regulatory Officer

Jason Duncan

General Counsel

Jan Mattsson, Ph.D.

Chief Scientific Officer, Managing Director (Sweden), and Co-Founder

Simon Harford

Chief Financial Officer

Patrick Horn, M.D., Ph.D.

Chief Medical Officer

Pamela Stephenson

Chief Commercial Officer

Michelle Graham

Chief Human Resources Officer